NCT05615467View on ClinicalTrials.gov

A Study of Effect of LY3556050 on Metformin in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

December 27, 2022

Study Completion Date

December 27, 2022

Conditions

Healthy

Interventions

DRUG

LY3556050

Administered orally.

DRUG

Metformin

Administered orally.

DRUG

Iohexol

Administered IV.

Trial Locations (1)

84124

PRA International, Salt Lake City

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY